Galal Sara Ahmed, Ali Mona Sobh, A HafizHala Hala Shawky
Dermatology and Venereology Department, Faculty of Medicine (Girls), Al-Azhar University, 53, New Cairo, 3rd Zone Fifth, Settlement, Cairo, Egypt.
Lasers Med Sci. 2025 Jan 11;40(1):16. doi: 10.1007/s10103-024-04269-8.
Androgenic alopecia (AGA) is the most common form of non-scarring hair loss, characterized by marked hair follicle miniaturization. AGA is a challenging skin condition with limited treatment results. Laser light can promote hair growth at specific wavelengths. The efficacy of fractional CO2 laser in scalp AGA treatment was reported in a few studies. We aimed to compare the efficacy of fractional CO2 laser alone versus the combination of fractional CO2 laser with topical dutasteride in the treatment of male AGA. 30 male patients with AGA were enrolled in the study; they were divided into two groups. All patients received three sessions of ablative fractional CO2 laser one month apart on the scalp, where group (I) patients were subjected to laser sessions only, and group (II) patients were subjected to topical dutasteride, first immediately after each session and secondly fifteen days after each session. The evaluation was done according to dermoscopy (DermLite DL4) and photographic assessment. Patient satisfaction and side effects were reported. According to the global photo assessment, the combination of fractional CO2 laser with topical dutasteride showed a statistically significant improvement compared to the fractional CO2 laser alone group. The combination of fractional CO2 laser with topical dutasteride is more efficient in improving male androgenic alopecia than fractional CO2 laser alone according to the investigator's global assessment. There was a significant improvement in all dermoscopic parameters in both groups.
雄激素性脱发(AGA)是最常见的非瘢痕性脱发形式,其特征为明显的毛囊小型化。AGA是一种具有挑战性的皮肤疾病,治疗效果有限。特定波长的激光可促进头发生长。少数研究报道了剥脱性二氧化碳点阵激光治疗头皮AGA的疗效。我们旨在比较单纯剥脱性二氧化碳点阵激光与剥脱性二氧化碳点阵激光联合外用度他雄胺治疗男性AGA的疗效。30例男性AGA患者纳入本研究;他们被分为两组。所有患者在头皮上每隔一个月接受三次剥脱性二氧化碳点阵激光治疗,其中(I)组患者仅接受激光治疗,(II)组患者在每次治疗后立即以及每次治疗后15天接受外用度他雄胺治疗。根据皮肤镜检查(DermLite DL4)和照片评估进行评价。报告了患者满意度和副作用。根据整体照片评估,与单纯剥脱性二氧化碳点阵激光组相比,剥脱性二氧化碳点阵激光联合外用度他雄胺显示出统计学上的显著改善。根据研究者的整体评估,剥脱性二氧化碳点阵激光联合外用度他雄胺在改善男性雄激素性脱发方面比单纯剥脱性二氧化碳点阵激光更有效。两组的所有皮肤镜参数均有显著改善。